CIBC Bancorp USA’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$191K Buy
20,763
+2,378
+13% +$26.5K ﹤0.01% 1791
2026
Q1
$199K Buy
+18,385
New +$157K ﹤0.01% 1621
2025
Q3
$195K Buy
+37,669
New +$217K ﹤0.01% 1270

Other funds holding PTEN

CIBC Bancorp USA's PTEN Position: Q2 2026 in Review

CIBC Bancorp USA increased its Patterson-UTI (PTEN) stake by 13% in Q2 2026, buying an estimated $26.5K and bringing the position to 20,763 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

CIBC Bancorp USA first reported a position in PTEN in Q3 2025 and has held it in 3 quarters since. The position peaked at $199K in Q1 2026. 405 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • CIBC Bancorp USA held 20,763 shares of Patterson-UTI worth $191K as of Q2 2026.
  • CIBC Bancorp USA bought 2,378 Patterson-UTI shares in Q2 2026, an estimated $26.5K.
  • Patterson-UTI made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1791 holding.
  • CIBC Bancorp USA first reported a position in Patterson-UTI in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Patterson-UTI position peaked at $199K in Q1 2026.
  • 405 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.